Clinical trial
Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered…
NCT00192140 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00192140 |
|---|---|
| Title | Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age |
| Official title | An Open-Label, Single-Arm Trial to Assess the Shedding, Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age |
| Lead sponsor | MedImmune LLC, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | FluMist |
| Enrollment | 345 |
| Start date | Jun 1, 2004 |
| Primary completion | Oct 1, 2004 |
| Completion | Jan 1, 2005 |
| First posted | Sep 19, 2005 |
| Last update posted | Dec 28, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: